Our Strategy
We’re on course to transform the practice of medicine through breakthrough science and make a positive impact on our people and the communities we serve.
Transforming the practice of medicine
Prioritization and focus are helping us unlock and maximize the potential of key medicines, vaccines, and self-care solutions for people, across our global business units: Specialty Care, Vaccines, General Medicines, and Consumer Healthcare.
We aim to become a leading company in immunology and positively impact millions of patients suffering from dermatological, respiratory, gastroenterological, and other immune-mediated diseases.
We earn every day our leadership in prevention by protecting half a billion people worldwide every year with our portfolio of vaccines and by leveraging our broad set of technology and manufacturing platforms, including in mRNA.
Advancing breakthrough science
We’re strengthening our pipeline with a steady stream of potentially transformative therapies that could shift paradigms in treatment and prevention for people across the world.
We have a powerful toolbox of drug discovery platforms that allow us to break scientific ground in six therapeutic areas: Immunology and Inflammation, Oncology, Rare Diseases, Rare Blood Disorders, Neurology and Vaccines.
Driving social impact
The challenges facing society and the planet are becoming increasingly more complex. Shifting demographics, persistent inequalities in access to healthcare, and accelerating threats from climate change have motivated us to expand our commitments to society.
Our social impact strategy is differentiated from our peers, multi-faceted and embedded at all levels of our organization. We aim to have a transformative and sustainable impact on the health and well-being of people, vulnerable communities, our employees, and the planet.
MAT-XU-2305276 (v1.0)
March 2024